Simon Bayly

@simonbayly

Life sciences BD factotum for a bioengineering and diagnostics startup. Also tweet about bicycles 🚲

Oxford
Vrijeme pridruživanja: prosinac 2010.

Tweetovi

Blokirali ste korisnika/cu @simonbayly

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @simonbayly

  1. prije 2 sata
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet

    Interested in pitching to top UK and EU investors focused on early-stage and scale-up life science and medtech companies? Apply for a spot now.

    Poništi
  3. prije 2 sata

    This could be very useful for Oxford deep tech startups

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    prije 3 sata

    Monday we sequenced the genome of the first Belgium case with MinION. Suspected sample received @ 9 pm, confirmed and full genome out @ 5 am. From suspected sample to result in 8 hours. All thanks to our great team , and protocols of

    Poništi
  5. prije 5 sati

    I wonder what my friends who helped the drug discovery software company Oxford Molecular attain market cap of £450M in the 1990s would make of it.

    Prikaži ovu nit
    Poništi
  6. prije 8 sati

    Just one example - 20 years ago Vijay himself created and launched to help understand protein folding.

    Prikaži ovu nit
    Poništi
  7. prije 8 sati

    Absolute bullshit opening statement. Software has been making an impact in drug discovery for at least 30 years.

    Prikaži ovu nit
    Poništi
  8. prije 8 sati

    'Genome' is one hell of a functional group 🙃

    Poništi
  9. prije 8 sati

    Now you can play with the nCoV protease structure on PDB

    Poništi
  10. proslijedio/la je Tweet
    2. velj

    Pitchbook's email blast on 1/30/20 noted that "Life sciences deals outperform other sectors on an adjusted basis, despite a risky reputation." Full report can be downloaded here:

    Poništi
  11. proslijedio/la je Tweet
    4. velj

    Interesting (and unsurprising) chart from HBM's 2020 M&A Report: Investment return multiples for M&A exits of VC-backed companies decline by stage, capturing the impact of dilution from capital raises required to advance a pipeline.

    Prikaži ovu nit
    Poništi
  12. 4. velj

    Missed this - one of Oxford's fusion startups is scaling up

    Poništi
  13. 4. velj

    If A16Z carries on in this direction, they will end up looking and investing like a traditional biotech firm

    Prikaži ovu nit
    Poništi
  14. 4. velj

    Those recent biotech op-eds, manifestos etc. from A16Z must have really hit the mark!

    Prikaži ovu nit
    Poništi
  15. 4. velj

    Any mention of whaling and I can't help thinking of this:

    Prikaži ovu nit
    Poništi
  16. 4. velj

    🔥🔥🔥🔥🔥 "The VC sector is full of too many over-funded, ill-disciplined chancers who pass off hype for reality, groupthink for insight and luck for good judgement" 🔥🔥🔥🔥🔥

    Prikaži ovu nit
    Poništi
  17. 4. velj

    Excellent monthly curated list of the most interesting CAR-T papers:

    Poništi
  18. proslijedio/la je Tweet
    2. velj

    A qPCR Explainer. This is intended for reporters, financial types and other non-experts interested in better understanding this technology and how it is used in diagnostic tests for the Wuhan coronavirus.

    Prikaži ovu nit
    Poništi
  19. 31. sij

    What's all this then?

    Poništi
  20. proslijedio/la je Tweet
    Odgovor korisniku/ci

    We think that the culture of the VC industry (even the common lingo!) tends to tear down founder empathy, even among those who start with high empathy. We're petrified of falling into this trap ourselves. Actually planning on writing a blog post about this soon.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·